Exogenously Delivered IPSCs Disrupt the Natural Repair Response of Endogenous MPCs After Bone Injury

Overview

Journal Sci Rep

Specialty Science

Date 2023 Jun 9

PMID 37296277

Authors

Leah Ferrie

Priyatha Premnath

Alexandra Olsen

Leila Larijani

Bryce A Besler

Derrick E Rancourt

Neil A Duncan

T Michael Underhill

Roman J Krawetz

Affiliations

Soon will be listed here.

Abstract

Promoting bone healing including fracture non-unions are promising targets for bone tissue engineering due to the limited success of current clinical treatment methods. There has been significant research on the use of stem cells with and without biomaterial scaffolds to treat bone fractures due to their promising regenerative capabilities. However, the relative roles of exogenous vs. endogenous stem cells and their overall contribution to in vivo fracture repair is not well understood. The purpose of this study was to determine the interaction between exogenous and endogenous stem cells during bone healing. This study was conducted using a standardized burr-hole bone injury model in a mesenchymal progenitor cell (MPC) lineage-tracing mouse under normal homeostatic and osteoporotic conditions. Burr-hole injuries were treated with a collagen-I biomaterial loaded with and without labelled induced pluripotent stem cells (iPSCs). Using lineage-tracing, the roles of exogenous and endogenous stem cells during bone healing were examined. It was observed that treatment with iPSCs resulted in muted healing compared to untreated controls in intact mice post-injury. When the cell populations were examined histologically, iPSC-treated burr-hole defects presented with a dramatic reduction in endogenous MPCs and cell proliferation throughout the injury site. However, when the ovaries were removed and an osteoporotic-like phenotype induced in the mice, iPSCs treatment resulted in increased bone formation relative to untreated controls. In the absence of iPSCs, endogenous MPCs demonstrated robust proliferative and osteogenic capacity to undertake repair and this behaviour was disrupted in the presence of iPSCs which instead took on an osteoblast fate but with little proliferation. This study clearly demonstrates that exogenously delivered cell populations can impact the normal function of endogenous stem/progenitor populations during the normal healing cascade. These interactions need to be better understood to inform cell and biomaterial therapies to treat fractures.

References

Wei Q, Huang L, Tan X, Chen Z, Chen S, Deng W . Serum osteopontin levels in relation to bone mineral density and bone turnover markers in postmenopausal women. Scand J Clin Lab Invest. 2015; 76(1):33-9. DOI: 10.3109/00365513.2015.1087045. View

Cho E, Cho K, Lee H, Kim S . High serum osteopontin levels are associated with low bone mineral density in postmenopausal women. J Korean Med Sci. 2013; 28(10):1496-9. PMC: 3792605. DOI: 10.3346/jkms.2013.28.10.1496. View

Abbasi S, Sinha S, Labit E, Rosin N, Yoon G, Rahmani W . Distinct Regulatory Programs Control the Latent Regenerative Potential of Dermal Fibroblasts during Wound Healing. Cell Stem Cell. 2020; 27(3):396-412.e6. DOI: 10.1016/j.stem.2020.07.008. View

Soliman H, Paylor B, Scott R, Lemos D, Chang C, Arostegui M . Pathogenic Potential of Hic1-Expressing Cardiac Stromal Progenitors. Cell Stem Cell. 2020; 26(2):205-220.e8. DOI: 10.1016/j.stem.2019.12.008. View

Pereira T, Syn W, Pereira F, Lambertucci J, Secor W, Diehl A . Serum osteopontin is a biomarker of severe fibrosis and portal hypertension in human and murine schistosomiasis mansoni. Int J Parasitol. 2016; 46(13-14):829-832. PMC: 5584370. DOI: 10.1016/j.ijpara.2016.08.004. View

Hu D, Ferro F, Yang F, Taylor A, Chang W, Miclau T . Cartilage to bone transformation during fracture healing is coordinated by the invading vasculature and induction of the core pluripotency genes. Development. 2017; 144(2):221-234. PMC: 5394763. DOI: 10.1242/dev.130807. View

Zhu W, Gramlich O, Laboissonniere L, Jain A, Sheffield V, Trimarchi J . Transplantation of iPSC-derived TM cells rescues glaucoma phenotypes in vivo. Proc Natl Acad Sci U S A. 2016; 113(25):E3492-500. PMC: 4922164. DOI: 10.1073/pnas.1604153113. View

Chen L, Tredget E, Wu P, Wu Y . Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One. 2008; 3(4):e1886. PMC: 2270908. DOI: 10.1371/journal.pone.0001886. View

Schlundt C, Bucher C, Tsitsilonis S, Schell H, Duda G, Schmidt-Bleek K . Clinical and Research Approaches to Treat Non-union Fracture. Curr Osteoporos Rep. 2018; 16(2):155-168. DOI: 10.1007/s11914-018-0432-1. View

10.

Tseng S, Lee M, Reddi A . Nonunions and the potential of stem cells in fracture-healing. J Bone Joint Surg Am. 2008; 90 Suppl 1:92-8. DOI: 10.2106/JBJS.G.01192. View

11.

Taiani J, Krawetz R, Yamashita A, Pauchard Y, Buie H, Ponjevic D . Embryonic stem cells incorporate into newly formed bone and do not form tumors in an immunocompetent mouse fracture model. Cell Transplant. 2012; 22(8):1453-62. DOI: 10.3727/096368912X658755. View

12.

Colnot C . Skeletal cell fate decisions within periosteum and bone marrow during bone regeneration. J Bone Miner Res. 2008; 24(2):274-82. PMC: 3276357. DOI: 10.1359/jbmr.081003. View

13.

Taiani J, Buie H, Campbell G, Manske S, Krawetz R, Rancourt D . Embryonic stem cell therapy improves bone quality in a model of impaired fracture healing in the mouse; tracked temporally using in vivo micro-CT. Bone. 2014; 64:263-72. DOI: 10.1016/j.bone.2014.04.019. View

14.

Alfred R, Taiani J, Krawetz R, Yamashita A, Rancourt D, Kallos M . Large-scale production of murine embryonic stem cell-derived osteoblasts and chondrocytes on microcarriers in serum-free media. Biomaterials. 2011; 32(26):6006-16. DOI: 10.1016/j.biomaterials.2011.04.015. View

15.

Obermeyer T, Yonick D, Lauing K, Stock S, Nauer R, Strotman P . Mesenchymal stem cells facilitate fracture repair in an alcohol-induced impaired healing model. J Orthop Trauma. 2012; 26(12):712-8. PMC: 3645443. DOI: 10.1097/BOT.0b013e3182724298. View

16.

Sui S, Yu H, Wang X, Wang W, Yang X, Pan X . iPSC-Derived Trabecular Meshwork Cells Stimulate Endogenous TM Cell Division Through Gap Junction in a Mouse Model of Glaucoma. Invest Ophthalmol Vis Sci. 2021; 62(10):28. PMC: 8399400. DOI: 10.1167/iovs.62.10.28. View

17.

Huang S, Xu L, Zhang Y, Sun Y, Li G . Systemic and Local Administration of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells Promotes Fracture Healing in Rats. Cell Transplant. 2015; 24(12):2643-55. DOI: 10.3727/096368915X687219. View

18.

Logan M, Martin J, Nagy A, Lobe C, Olson E, Tabin C . Expression of Cre Recombinase in the developing mouse limb bud driven by a Prxl enhancer. Genesis. 2002; 33(2):77-80. DOI: 10.1002/gene.10092. View

19.

Jeon O, Panicker L, Lu Q, Chae J, Feldman R, Elisseeff J . Human iPSC-derived osteoblasts and osteoclasts together promote bone regeneration in 3D biomaterials. Sci Rep. 2016; 6:26761. PMC: 4881234. DOI: 10.1038/srep26761. View

20.

Taiani J, Krawetz R, Zur Nieden N, Wu Y, Kallos M, Matyas J . Reduced differentiation efficiency of murine embryonic stem cells in stirred suspension bioreactors. Stem Cells Dev. 2009; 19(7):989-98. PMC: 3128313. DOI: 10.1089/scd.2009.0297. View